BeOne Medicines Ltd. (ONC)
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
BeOne Medicines AG
NASDAQ:ONCHealthcare · Biotechnology
-0.33%$370.33
AH$370.33+0.00%vs close
Mkt Cap$41.89B
Float60.73M
O/S113.12M
Vol
$ Vol
RVOL
Inst Own22.5%
SI3.0%
Earnings
Dilution
Financials Summary
Revenue$5.34B
Net Income$286.93M
Total Assets$8.19B
Free Cash Flow$941.74M
Debt & Equity
Debt 31%
Equity 69%
Total Debt$2B
Total Equity$4.36B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ONC's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$8.19B
Liabilities$3.83B
Accounts Receivable$886.86M
Accounts Payable$479.04M
Inventory$608.23M
PP&E (Net)$1.79B
Goodwill$0
Intangible Assets$62.7M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $5.34B | $3.81B | $2.46B | $1.42B | $1.18B | $308.87M | $428.21M | $198.22M | $238.39M | $1.07M | $8.82M | $13.04M | $11.15M |
| YoY Growth | 40.2% | 55.0% | 73.7% | 20.4% | 280.8% | -27.9% | 116.0% | -16.8% | 22179.2% | -87.9% | -32.4% | 16.9% | - |
| Cost of Revenue | $668.54M | $594.09M | $379.92M | $286.48M | $164.91M | $70.66M | $71.19M | $707.71M | $273.99M | $98.03M | $58.25M | $21.86M | $13.46M |
| Gross Profit | $4.67B | $3.22B | $2.08B | $1.13B | $1.01B | $238.22M | $357.02M | -$509.49M | -$35.6M | -$96.96M | -$49.43M | -$8.83M | -$2.31M |
| Gross Margin | 87.5% | 84.4% | 84.5% | 79.8% | 86.0% | 77.1% | 83.4% | -257.0% | -14.9% | -9062.0% | -560.7% | -67.7% | -20.8% |
| Research and Development | $2.15B | $1.95B | $1.78B | $1.64B | $1.46B | $1.29B | $927.34M | $679M | $269.02M | $98.03M | $58.25M | $21.86M | $13.46M |
| Selling, General, and Administrative | $2.08B | $1.83B | $1.51B | $1.28B | $990.12M | $600.18M | $388.25M | $195.38M | $62.6M | $20.1M | $7.31M | $6.93M | $3.14M |
| Other | $0 | $0 | $0 | $0 | $750K | $846K | $1.33M | $1.99M | $11.46M | -$2.49M | -$916K | $600K | $584K |
| Total Operating Expenses | $4.23B | $3.78B | $3.29B | $2.92B | $2.45B | $1.9B | $1.32B | $196.28M | $62.85M | $20.1M | $7.31M | $6.93M | $3.14M |
| Operating Income (EBIT) | $447.14M | -$568.2M | -$1.21B | -$1.79B | -$1.44B | -$1.66B | -$959.89M | -$705.77M | -$98.46M | -$117.06M | -$56.74M | -$15.76M | -$5.46M |
| Operating Margin | 8.4% | -14.9% | -49.1% | -126.4% | -122.3% | -536.7% | -224.2% | -356.1% | -41.3% | -10940.2% | -643.7% | -120.9% | -49.0% |
| Interest Expense | $58.23M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4.11M | $383K | $0 | $3.55M | $3.15M |
| Interest Income | $70.5M | $47.84M | $74.01M | $52.48M | $15.76M | $2M | $9.13M | $13.95M | $0 | $0 | $559K | $40K | $2K |
| Other Income (Expense) | -$30.28M | $35.2M | $381.9M | -$171.37M | $147K | $39.49M | $16.3M | $15.94M | $7.39M | -$2.1M | -$357K | -$2.79M | -$2.44M |
| Income Before Tax (EBT) | $416.85M | -$533M | -$825.84M | -$1.96B | -$1.44B | -$1.62B | -$943.59M | -$689.83M | -$91.06M | -$119.16M | -$57.1M | -$18.55M | -$7.89M |
| Income Tax Expense | $129.92M | $111.78M | $55.87M | $42.78M | $19.23M | $10.4M | $6.99M | -$15.8M | $2.23M | $54K | $0 | $0 | $0 |
| Net Income | $286.93M | -$644.79M | -$881.71M | -$2B | -$1.46B | -$1.62B | -$948.63M | -$673.77M | -$93.11M | -$119.22M | -$57.1M | -$18.28M | -$7.49M |
| Net Income Margin | 5.4% | -16.9% | -35.9% | -141.5% | -123.9% | -526.1% | -221.5% | -339.9% | -39.1% | -11141.8% | -647.7% | -140.2% | -67.2% |
| Supplementary Data | |||||||||||||
| EPS | 33.80 | -6.12 | -8.45 | -19.37 | -15.21 | -19.11 | -15.86 | -12.09 | -2.21 | -3.90 | -1.82 | -0.35 | -1.43 |
| Diluted EPS | 32.11 | -6.12 | -8.45 | -19.37 | -15.21 | -19.11 | -15.86 | -12.09 | -2.21 | -3.90 | -1.82 | -0.35 | -1.43 |
| Weighted Average OS | 109.06M | 105.29M | 104.39M | 103.13M | 92.79M | 83.47M | 60.05M | 55.44M | 41.78M | 31.05M | 31.52M | 52.66M | 5.27M |
| EBITDA | $616.77M | -$361.24M | -$738.16M | -$1.89B | -$1.39B | -$1.63B | -$941.27M | -$695.38M | -$93.7M | -$115.15M | -$55.2M | -$14.2M | -$3.15M |
| EBITDA Margin | 11.5% | -9.5% | -30.0% | -133.8% | -118.4% | -526.4% | -219.8% | -350.8% | -39.3% | -10761.8% | -626.1% | -108.9% | -28.2% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $4.55B | $2.63B | $3.17B | $3.87B | $4.38B | $1.38B | $618.01M | $712.94M | $239.6M | $87.51M | $17.87M | $13.9M | $3.93M |
| Short-Term Investments | $0 | $0 | $2.6M | $665.25M | $2.24B | $3.27B | $364.73M | $1.07B | $597.91M | $280.66M | $82.62M | $30.5M | $0 |
| Cash and Short-Term Investments | $4.55B | $2.63B | $3.17B | $4.53B | $6.62B | $4.65B | $982.74M | $1.78B | $837.52M | $368.17M | $100.49M | $44.4M | $3.93M |
| Accounts Receivable | $886.86M | $709.11M | $395.89M | $198.98M | $500.18M | $60.4M | $70.88M | $49.67M | $29.43M | $0 | $0 | $0 | $0 |
| Inventory | $608.23M | $494.99M | $416.12M | $282.35M | $242.63M | $89.29M | $28.55M | $16.24M | $10.93M | $0 | $0 | $0 | $0 |
| Other Current Assets | $60.24M | $25.19M | $56.25M | $196K | $328K | $19.58M | $76.49M | $17.64M | $25.73M | $0 | $0 | $0 | $0 |
| Total Current Assets | $6.23B | $3.99B | $4.2B | $5.21B | $7.61B | $4.96B | $1.17B | $1.94B | $913.5M | $374.4M | $106.27M | $47.19M | $4.43M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $1.79B | $1.66B | $1.37B | $923.98M | $662.51M | $446.3M | $324.92M | $194.24M | $62.57M | $25.98M | $6.61M | $5.93M | $7.05M |
| Goodwill | $0 | $0 | $0 | $0 | $109K | $109K | $109K | $109K | $109K | $0 | $0 | $0 | $0 |
| Intangible Assets | $62.7M | $129.76M | $108.86M | $94.57M | $103.35M | $53.73M | $5.85M | $52.23M | $19.71M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $82.51M | $128.93M | $89.64M | $91.78M | $100.79M | $49.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $110.42M | $65.96M | $0 | $29.54M | $7.67M | $768K | $0 | $0 | $0 |
| Other Long-Term Assets | $19.91M | $13.38M | $31.57M | $61.89M | -$55.53M | $24.62M | $108.72M | $29.73M | $42.91M | $4.67M | $3.88M | $502K | $312K |
| Total Long-Term Assets | $1.95B | $1.93B | $1.6B | $1.17B | $921.64M | $640.07M | $439.59M | $305.84M | $132.98M | $31.41M | $10.49M | $6.43M | $7.36M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $8.19B | $5.92B | $5.81B | $6.38B | $8.54B | $5.6B | $1.61B | $2.25B | $1.05B | $405.81M | $116.76M | $53.62M | $11.8M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $479.04M | $405M | $315.11M | $294.78M | $262.4M | $231.96M | $122.49M | $113.28M | $69.78M | $11.96M | $8.98M | $2.79M | $2.06M |
| Short-Term Debt | $134.71M | $851.53M | $688.37M | $328.97M | $427.56M | $335.01M | $0 | $8.73M | $9.22M | $0 | $14.6M | $322K | $20M |
| Current Income Tax Payable | $41.63M | $60.83M | $53.03M | $44M | $67.06M | $34.75M | $0 | $13.92M | $9.16M | $804K | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $213.86M | $187.41M | $0 | $0 | $18.14M | $12.23M | $0 | $1.07M | $8.91M | $7.86M |
| Other Current Liabilities | $1.22B | $359.5M | $285.81M | $299.11M | $260.77M | $234.57M | $56.86M | $31.08M | $18.98M | $804K | $4.8M | $643K | $8.93M |
| Total Current Liabilities | $1.83B | $2.21B | $1.81B | $1.47B | $1.6B | $1.08B | $310.31M | $246.45M | $149.99M | $35.06M | $35.17M | $13.37M | $31.73M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $1.81B | $166.48M | $197.62M | $209.15M | $202.11M | $183.64M | $240.69M | $189.67M | $155.49M | $17.28M | $6.19M | $13.52M | $15.24M |
| Long-Term Unearned Revenue | $0 | $30.32M | $34.2M | $80.2M | $266.64M | $49.14M | $0 | $47.69M | $56.61M | $564K | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $97.21M | $42.01M | $16.49M | $16M | $14.17M | $10.79M | $0 | $11.14M | $0 | -$564K | $0 | $0 | $0 |
| Other Long-Term Liabilities | $51.27M | $90.7M | $187.27M | $187.54M | $277.44M | $383.33M | $57.09M | $1.08M | $155K | $564K | $1.08M | $966K | $3.55M |
| Total Long-Term Liabilities | $2.01B | $373.79M | $457.83M | $527.41M | $803.41M | $656.32M | $323.62M | $249.59M | $212.26M | $17.85M | $7.27M | $14.48M | $18.79M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3.83B | $2.59B | $2.27B | $2B | $2.4B | $1.73B | $633.93M | $496.04M | $362.25M | $52.91M | $42.45M | $27.85M | $48.76M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.45M | $14.42M | $0 | $176.08M | $78.81M | $0 |
| Common Stock | $144K | $138K | $135K | $135K | $133K | $118K | $79K | $77K | $59K | $52K | $12K | $23K | $9K |
| Retained Earnings | -$8.32B | -$8.61B | -$7.96B | -$7.08B | -$5.08B | -$3.55B | -$1.96B | -$1.01B | -$330.52M | -$237.41M | -$118.19M | -$61.09M | -$42.81M |
| Comprehensive Income & Other | -$78.18M | -$148.99M | -$99.45M | -$77.42M | $17.95M | $6.94M | -$8M | $1.53M | -$480K | -$946K | -$1.81M | $100K | $309K |
| Other Stockholders' Equity | $12.68B | $11.94B | $11.5B | $11.46B | $11.21B | $7.42B | $2.92B | $2.76B | $1.01B | $590.27M | $16.42M | $86.84M | $4.08M |
| Total Equity | $4.36B | $3.33B | $3.54B | $4.38B | $6.13B | $3.87B | $962.21M | $1.75B | $684.23M | $352.91M | -$101.77M | $25.77M | -$38.73M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $16.15M | $14.45M | $14.42M | $0 | $0 | $0 | $1.77M |
| Total Liabilities and Equity | $8.19B | $5.92B | $5.81B | $6.38B | $8.54B | $5.6B | $1.6B | $2.25B | $1.05B | $405.81M | -$59.32M | $53.62M | $10.03M |
| Supplementary Data | |||||||||||||
| Total Debt | $2B | $1.08B | $930.18M | $596.67M | $694.64M | $561.96M | $277.34M | $198.4M | $164.72M | $17.28M | $20.79M | $13.84M | $27.36M |
| Net Debt | -$2.55B | -$1.55B | -$2.24B | -$3.27B | -$3.68B | -$819.99M | -$340.67M | -$514.54M | -$74.89M | -$70.23M | $2.92M | -$60K | $23.44M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | $286.93M | -$644.79M | -$881.71M | -$2B | -$1.41B | -$1.6B | -$950.58M | -$674.03M | -$93.3M | -$119.22M | -$57.1M | -$18.55M | -$7.89M |
| Depreciation & Amortization | $141.69M | $171.76M | $87.67M | $66.28M | $46.46M | $31.79M | $18.62M | $10.39M | $4.76M | $1.91M | $1.54M | $1.56M | $1.59M |
| Deferred Income Tax | $9.47M | $25.98M | $689K | $2.06M | -$41.09M | -$27.81M | -$9.23M | -$21.95M | -$5.84M | $2.93M | $2.15M | -$70K | -$112K |
| Stock-Based Compensation | $510.86M | $441.62M | $367.62M | $303.16M | $240.71M | $183.48M | $134.15M | $87.13M | $42.86M | $10.63M | $10.21M | $6.64M | -$24K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | -$164.95M | -$329.44M | -$188.31M | $304.11M | -$423.02M | $10.36M | -$29.82M | -$11.63M | -$29.43M | $0 | $0 | $0 | $0 |
| Inventory | -$93.17M | -$91.5M | -$140.95M | -$56.69M | -$153.33M | -$58.91M | -$12.31M | -$5.31M | -$10.93M | $0 | $0 | $0 | $0 |
| Accounts Payable | $79.83M | $121.5M | $21.48M | -$4.35M | $20.01M | $95.83M | $2.22M | $23.47M | $55.3M | $2.71M | $6.19M | $731K | -$768K |
| Other Working Capital | $370.16M | $142.28M | -$62.77M | -$110.68M | $438M | $103.29M | $29.08M | -$23.74M | $42.26M | $11.41M | -$3.92M | -$2.27M | $8.51M |
| Total Working Capital Change | $191.4M | -$157.17M | -$370.54M | $132.39M | -$118.34M | $150.58M | -$10.83M | -$17.21M | $57.2M | $14.12M | $2.26M | -$1.54M | $7.75M |
| Other Non-Cash Items | -$12.77M | $21.96M | -$361.19M | $3.31M | -$13.11M | -$20.98M | $67.6M | $67.96M | $7.08M | $121K | $1.09M | $3.27M | $2.77M |
| Net Cash from Operating | $1.13B | -$140.63M | -$1.16B | -$1.5B | -$1.3B | -$1.28B | -$750.27M | -$547.72M | $12.75M | -$89.51M | -$39.84M | -$8.69M | $4.07M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$185.84M | -$492.66M | -$561.9M | -$469.1M | -$314.85M | -$229.03M | -$158.61M | -$140.84M | -$58.73M | -$23.5M | -$5.31M | -$654K | -$264K |
| Acquisitions | $0 | $0 | $0 | -$1.4B | $51.91M | $109.5M | $69M | $70.55M | $19.92M | $0 | $0 | -$2.44M | $0 |
| Purchases of Investments | -$11.83M | -$19.01M | -$14.9M | -$17.4M | -$2.19B | -$5.69B | -$1.17B | -$2.64B | -$741.3M | -$382.09M | -$119.29M | -$30.65M | $0 |
| Sales of Investments | $3.45M | $2.65M | $673.24M | $1.56B | $3.15B | $2.75B | $1.88B | $2.18B | $423.79M | $183.74M | $65.7M | $102K | $0 |
| Other Investing Activities | -$81.93M | -$39.34M | -$36.44M | $1.4B | -$51.91M | -$109.5M | -$69M | -$108.85M | -$329.86M | $4K | $1K | -$30.54M | $14K |
| Net Cash from Investing | -$276.15M | -$548.35M | $60M | $1.08B | $640.66M | -$3.17B | $554.16M | -$637.61M | -$356.32M | -$221.85M | -$58.91M | -$33.64M | -$250K |
| Financing Activities | |||||||||||||
| Debt Repaid | -$1.7B | $18.98M | -$8.81M | -$37.37M | -$16.84M | $21.85M | -$34.68M | -$33.58M | -$132.76M | -$12.05M | -$6.17M | -$17.52M | - |
| Common Stock Issuance | $196.8M | $0 | $0 | $0 | $3.44B | $4.23B | $0 | $1.63B | $339.12M | $368.88M | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$75K | -$80K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$27.06M | $48.37M | $55.71M | $46.96M | $92.76M | $681.21M | $51M | $29.66M | $18.48M | -$23K | $77K | -$1.1M | -$482K |
| Net Cash from Financing | $1.06B | $193.45M | $416.48M | -$18.97M | $3.64B | $5.2B | $85.68M | $1.69B | $490.36M | $380.9M | $103.2M | $52.16M | -$482K |
| Forex Effect | $60.02M | -$51.7M | -$8.08M | -$69.38M | $14.04M | $18.23M | -$9.51M | -$4.1M | $5.3M | $104K | -$485K | $142K | -$41K |
| Net Change in Cash | $1.97B | -$547.24M | -$689.05M | -$507.85M | $2.99B | $769.23M | -$119.94M | $501.11M | $152.09M | $69.64M | $3.97M | $9.97M | $3.3M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | $1.13B | -$140.63M | -$1.16B | -$1.5B | -$1.3B | -$1.28B | -$750.27M | -$547.72M | $12.75M | -$89.51M | -$39.84M | -$8.69M | $4.07M |
| Capital Expenditure | -$185.84M | -$529.14M | -$596.26M | -$469.1M | -$314.85M | -$229.03M | -$158.61M | -$140.84M | -$58.73M | -$23.5M | -$5.31M | -$654K | -$264K |
| Free Cash Flow | $941.74M | -$669.77M | -$1.75B | -$1.97B | -$1.61B | -$1.51B | -$908.88M | -$688.55M | -$45.98M | -$113.02M | -$45.16M | -$9.35M | $3.81M |
| Cash at Beginning | $2.64B | $3.19B | $3.88B | $4.38B | $1.39B | $620.77M | $740.71M | $239.6M | $87.51M | $17.87M | $13.9M | $3.93M | $626K |
| Cash at End | $4.61B | $2.64B | $3.19B | $3.88B | $4.38B | $1.39B | $620.77M | $740.71M | $239.6M | $87.51M | $17.87M | $13.9M | $3.93M |